Cargando…

Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts

RATIONALE: In Parkinson’s disease (PD), spatial covariance analysis of (18)F-FDG PET data has consistently revealed a characteristic PD-related brain pattern (PDRP). By quantifying PDRP expression on a scan-by-scan basis, this technique allows objective assessment of disease activity in individual s...

Descripción completa

Detalles Bibliográficos
Autores principales: Meles, Sanne K., Renken, Remco J., Pagani, Marco, Teune, L. K., Arnaldi, Dario, Morbelli, Silvia, Nobili, Flavio, van Laar, Teus, Obeso, Jose A., Rodríguez-Oroz, Maria C., Leenders, Klaus L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974499/
https://www.ncbi.nlm.nih.gov/pubmed/31768600
http://dx.doi.org/10.1007/s00259-019-04570-7
_version_ 1783490108901556224
author Meles, Sanne K.
Renken, Remco J.
Pagani, Marco
Teune, L. K.
Arnaldi, Dario
Morbelli, Silvia
Nobili, Flavio
van Laar, Teus
Obeso, Jose A.
Rodríguez-Oroz, Maria C.
Leenders, Klaus L.
author_facet Meles, Sanne K.
Renken, Remco J.
Pagani, Marco
Teune, L. K.
Arnaldi, Dario
Morbelli, Silvia
Nobili, Flavio
van Laar, Teus
Obeso, Jose A.
Rodríguez-Oroz, Maria C.
Leenders, Klaus L.
author_sort Meles, Sanne K.
collection PubMed
description RATIONALE: In Parkinson’s disease (PD), spatial covariance analysis of (18)F-FDG PET data has consistently revealed a characteristic PD-related brain pattern (PDRP). By quantifying PDRP expression on a scan-by-scan basis, this technique allows objective assessment of disease activity in individual subjects. We provide a further validation of the PDRP by applying spatial covariance analysis to PD cohorts from the Netherlands (NL), Italy (IT), and Spain (SP). METHODS: The PDRP(NL) was previously identified (17 controls, 19 PD) and its expression was determined in 19 healthy controls and 20 PD patients from the Netherlands. The PDRP(IT) was identified in 20 controls and 20 “de-novo” PD patients from an Italian cohort. A further 24 controls and 18 “de-novo” Italian patients were used for validation. The PDRP(SP) was identified in 19 controls and 19 PD patients from a Spanish cohort with late-stage PD. Thirty Spanish PD patients were used for validation. Patterns of the three centers were visually compared and then cross-validated. Furthermore, PDRP expression was determined in 8 patients with multiple system atrophy. RESULTS: A PDRP could be identified in each cohort. Each PDRP was characterized by relative hypermetabolism in the thalamus, putamen/pallidum, pons, cerebellum, and motor cortex. These changes co-varied with variable degrees of hypometabolism in posterior parietal, occipital, and frontal cortices. Frontal hypometabolism was less pronounced in “de-novo” PD subjects (Italian cohort). Occipital hypometabolism was more pronounced in late-stage PD subjects (Spanish cohort). PDRP(IT), PDRP(NL), and PDRP(SP) were significantly expressed in PD patients compared with controls in validation cohorts from the same center (P < 0.0001), and maintained significance on cross-validation (P < 0.005). PDRP expression was absent in MSA. CONCLUSION: The PDRP is a reproducible disease characteristic across PD populations and scanning platforms globally. Further study is needed to identify the topography of specific PD subtypes, and to identify and correct for center-specific effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-019-04570-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6974499
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-69744992020-02-03 Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts Meles, Sanne K. Renken, Remco J. Pagani, Marco Teune, L. K. Arnaldi, Dario Morbelli, Silvia Nobili, Flavio van Laar, Teus Obeso, Jose A. Rodríguez-Oroz, Maria C. Leenders, Klaus L. Eur J Nucl Med Mol Imaging Original Article RATIONALE: In Parkinson’s disease (PD), spatial covariance analysis of (18)F-FDG PET data has consistently revealed a characteristic PD-related brain pattern (PDRP). By quantifying PDRP expression on a scan-by-scan basis, this technique allows objective assessment of disease activity in individual subjects. We provide a further validation of the PDRP by applying spatial covariance analysis to PD cohorts from the Netherlands (NL), Italy (IT), and Spain (SP). METHODS: The PDRP(NL) was previously identified (17 controls, 19 PD) and its expression was determined in 19 healthy controls and 20 PD patients from the Netherlands. The PDRP(IT) was identified in 20 controls and 20 “de-novo” PD patients from an Italian cohort. A further 24 controls and 18 “de-novo” Italian patients were used for validation. The PDRP(SP) was identified in 19 controls and 19 PD patients from a Spanish cohort with late-stage PD. Thirty Spanish PD patients were used for validation. Patterns of the three centers were visually compared and then cross-validated. Furthermore, PDRP expression was determined in 8 patients with multiple system atrophy. RESULTS: A PDRP could be identified in each cohort. Each PDRP was characterized by relative hypermetabolism in the thalamus, putamen/pallidum, pons, cerebellum, and motor cortex. These changes co-varied with variable degrees of hypometabolism in posterior parietal, occipital, and frontal cortices. Frontal hypometabolism was less pronounced in “de-novo” PD subjects (Italian cohort). Occipital hypometabolism was more pronounced in late-stage PD subjects (Spanish cohort). PDRP(IT), PDRP(NL), and PDRP(SP) were significantly expressed in PD patients compared with controls in validation cohorts from the same center (P < 0.0001), and maintained significance on cross-validation (P < 0.005). PDRP expression was absent in MSA. CONCLUSION: The PDRP is a reproducible disease characteristic across PD populations and scanning platforms globally. Further study is needed to identify the topography of specific PD subtypes, and to identify and correct for center-specific effects. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00259-019-04570-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-11-25 2020 /pmc/articles/PMC6974499/ /pubmed/31768600 http://dx.doi.org/10.1007/s00259-019-04570-7 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Meles, Sanne K.
Renken, Remco J.
Pagani, Marco
Teune, L. K.
Arnaldi, Dario
Morbelli, Silvia
Nobili, Flavio
van Laar, Teus
Obeso, Jose A.
Rodríguez-Oroz, Maria C.
Leenders, Klaus L.
Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
title Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
title_full Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
title_fullStr Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
title_full_unstemmed Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
title_short Abnormal pattern of brain glucose metabolism in Parkinson’s disease: replication in three European cohorts
title_sort abnormal pattern of brain glucose metabolism in parkinson’s disease: replication in three european cohorts
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974499/
https://www.ncbi.nlm.nih.gov/pubmed/31768600
http://dx.doi.org/10.1007/s00259-019-04570-7
work_keys_str_mv AT melessannek abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT renkenremcoj abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT paganimarco abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT teunelk abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT arnaldidario abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT morbellisilvia abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT nobiliflavio abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT vanlaarteus abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT obesojosea abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT rodriguezorozmariac abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts
AT leendersklausl abnormalpatternofbrainglucosemetabolisminparkinsonsdiseasereplicationinthreeeuropeancohorts